Search results
Results From The WOW.Com Content Network
Since 2012, the World Health Organization (WHO) has recommended SMC as a treatment for malaria in Africa's sub-Sahel region. [ 7 ] Malaria Consortium began as a research consortium within the London School of Hygiene and Tropical Medicine and was originally funded solely by the UK Department for International Development (DFID, the Overseas ...
Research in Africa found a one-time dose of an experimental drug protected adults against malaria for at least six months, The post Antibody treatment tested as new tool against malaria appeared ...
Malaria is presently endemic in a broad band around the equator, in areas of the Americas, many parts of Asia, and much of Africa; in Sub-Saharan Africa, 85–90% of malaria fatalities occur. [221] An estimate for 2009 reported that countries with the highest death rate per 100,000 of population were Ivory Coast (86.15), Angola (56.93) and ...
The recommendation applies only for areas with high malaria transmission and low resistance against SP, both measures are not free of controversy and only available for few spots in Africa. With the recent drop of malaria transmission in wide stretches of Africa [30] [31] and a steady increase in SP resistance [32] [33] few malaria control ...
Target Malaria started as a university-based research programme in 2005. Since 2012, the project has expanded to include scientists, social scientists, stakeholder engagement experts, regulatory affairs experts, project management teams, risk assessment specialists and communications professionals from Africa, Europe, and North America.
His research considers the use of gene drive to eliminate malaria, and he leads Target Malaria Burkina Faso. He delivered the first genetically modified mosquitoes in Africa, marking a historic moment for science. He was awarded the 2023 Falling Walls Science Prize for Science and Innovation Management.
In sub-Saharan Africa, for example, where USAID oversees services including HIV prevention and treatment, girls and women ages 15 to 24 are three times more likely to contract the virus than boys ...
Greenwood's career has focused on mitigating the effects of malaria and pertinent research. [1] In his ten years experience working in Nigeria, and his fifteen years as the head of the Medical Research Council Laboratories in the Gambia, his main research interests were malaria and infections caused by capsulated bacteria such as the meningococcus (Neissera meningitidis).